JoVE Logo

Anmelden

3.2 : Drug Absorption Mechanism: Passive Membrane Transport

Passive transport is a method of drug absorption where small, lipid-soluble drugs can move across the cell membrane. This movement happens along the concentration gradient, which is a natural flow from higher to lower concentration areas. The speed at which the drug moves is directly related to its lipid–water partition coefficient. This means that the more a drug dissolves in lipids, the faster it diffuses or spreads throughout the body. It is important to note that most drugs are either weak acids or bases. The ionized forms of these drugs cannot dissolve in lipids and cannot cross the cell membrane. However, the nonionized forms that can dissolve in lipids can diffuse readily.

The distribution of a drug across a cell membrane depends on two factors: the drug's pKa and the pH gradient across the membrane. pKa refers to the acidity constant of the drug, while pH measures the acidity or alkalinity of the environment. Consider an example of a weakly acidic drug in stomach gastric juice. In the stomach, where the pH is lower than the drug's pKa, the drug remains primarily undissociated and can easily diffuse across the barrier. The drug dissociates readily once in the plasma, where the pH is higher than the drug's pKa. Because the ionized form of the drug cannot diffuse back through the barrier, this form is primarily found in the plasma.

Tags

Drug AbsorptionPassive TransportLipid soluble DrugsCell MembraneConcentration GradientLipid water Partition CoefficientWeak AcidsWeak BasesIonized FormsNonionized FormsPKaPH GradientGastric JuiceUndissociated DrugPlasma Diffusion

Aus Kapitel 3:

article

Now Playing

3.2 : Drug Absorption Mechanism: Passive Membrane Transport

Pharmacokinetics

3.6K Ansichten

article

3.1 : Pharmakokinetik: Überblick

Pharmacokinetics

5.4K Ansichten

article

3.3 : Absorptionsmechanismus von Medikamenten: Trägervermittelter Membrantransport

Pharmacokinetics

3.5K Ansichten

article

3.4 : Arzneimittelabsorption: Faktoren, die die gastrointestinale Absorption beeinflussen

Pharmacokinetics

3.8K Ansichten

article

3.5 : Bioverfügbarkeit: Überblick

Pharmacokinetics

2.7K Ansichten

article

3.6 : Faktoren, die die Bioverfügbarkeit beeinflussen: First-Pass-Eliminierung

Pharmacokinetics

6.1K Ansichten

article

3.7 : Bioäquivalenz: Überblick

Pharmacokinetics

915 Ansichten

article

3.8 : Effekt "Erster Durchgang"

Pharmacokinetics

5.0K Ansichten

article

3.9 : Zeitverlauf der Arzneimittelwirkung

Pharmacokinetics

1.9K Ansichten

article

3.10 : Wirkstoffverteilung: Gewebebindung

Pharmacokinetics

2.5K Ansichten

article

3.11 : Physiologische Barrieren

Pharmacokinetics

3.4K Ansichten

article

3.12 : Wirkstoffverteilung: Plasmaproteinbindung

Pharmacokinetics

4.8K Ansichten

article

3.13 : Fächermodelle: Modell mit nur einem Fach

Pharmacokinetics

2.1K Ansichten

article

3.14 : Fächermodelle: Modell mit zwei Fächern

Pharmacokinetics

5.2K Ansichten

article

3.15 : Arzneimittelverteilung: Volumen der Verteilung

Pharmacokinetics

4.4K Ansichten

See More

JoVE Logo

Datenschutz

Nutzungsbedingungen

Richtlinien

Forschung

Lehre

ÜBER JoVE

Copyright © 2025 MyJoVE Corporation. Alle Rechte vorbehalten